significance of p53 mutations in aml
Published 3 years ago • 254 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
3:25
the role of p53 mutation in lt in post mpn-aml
-
1:26
updates in the treatment landscape of p53-mutated aml/mds
-
3:03
mutant p53 re-activator apr-246 in mds/aml
-
5:16
an analysis of tp53 mutation in aml and hr-mds
-
1:08
novel strategies to target p53-mutant hematological malignancies
-
3:08
recent updates on tp53 mutation in cll
-
3:31
update on quantum-first: quizartinib soc chemotherapy & as continuation therapy in flt3-itd aml
-
6:39
treatment failure and relapse in acute myeloid leukemia (aml)
-
1:38
the importance of targeting tp53 in aml and agents being explored
-
2:26
impact of allelic state on os in tp53-mutant aml and hr-mds
-
0:46
the prognostic impact of tp53 mutation in mpns
-
3:47
the role of the pin1/pml/p53 axis in aml
-
1:36
the impact of tp53 mutations in patients with myelofibrosis undergoing sct
-
1:13
targeting p53 in mds
-
0:44
unmet needs in aml: tp53 mutations and maintenance therapy
-
3:00
apr-246 in tp53 mutated mds and aml
-
1:20
impact of tp53 mutations on outcomes in myelofibrosis
-
1:57
tolerability and efficacy of magrolimab plus azacitidine in tp53-mutated aml patients
-
1:59
depth of molecular response in patients with tp53m mds & aml treated with magrolimab and azacitidine
-
1:12
varied outcomes in patients with aml harboring poor-risk cytogenetics with or without tp53 mutation
-
0:41
promising agents in aml: menin inhibitors & magrolimab in tp53-mutated aml
-
8:14
progress in the treatment of tp53 mutated aml